Members

MassAffinity

By Evan Lim

23 September 2026

Back to all articles
Mass Affinity
MassAffinity

Share This

MassAffinity has developed a mass spectrometry-powered platform for drug discovery that combines multiplexed chemistry with high-throughput label-free screening. By generating huge chemical diversity and screening at scale, its workflows can move rapidly through chemical space, identify real interactions between molecules and proteins, and characterise the strength and selectivity of those interactions.